BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Angiogenesis
,
Pseudomonas infection
,
Leukocyte
,
Pharmacogenetics
,
Fluoxetine
,
SNCA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Hla, T
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)
T cells gene expression profiling of enriched CD4+CD25+HLADR+ and CD4+CD25-
L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations
CD8+ naive or activated T cells from PBMCs of dengue or dengue hemorrhagic patients
Explore Curated Studies Results
Literature
Most Relevant Literature
HLA-G Expression/Secretion and T-Cell Cytotoxicity in Missed Abortion in Comparison to Normal Pregna…
Tumor Escape Phenotype in Bladder Cancer Is Associated with Loss of HLA Class I Expression, T-Cell E…
SARS-CoV-2 Host Immunogenetic Biomarkers.
Current Perspectives on Severe Drug Eruption.
The HLA-Cw*06 allele and -1149 G/T polymorphism of extrapituitary promoter of PRL gene as a possible…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Trea…
Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Mali…
ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors
Genetically Modified Cells (KIND T Cells) for the Treatment of HLA-A*0201-Positive Patients With H3.…
Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ